These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 24175206)
1. Delivery strategies for novel vaccine formulations. Trovato M; Krebs SJ; Haigwood NL; De Berardinis P World J Virol; 2012 Feb; 1(1):4-10. PubMed ID: 24175206 [TBL] [Abstract][Full Text] [Related]
2. New recombinant vaccines based on the use of prokaryotic antigen-display systems. De Berardinis P; Haigwood NL Expert Rev Vaccines; 2004 Dec; 3(6):673-9. PubMed ID: 15606352 [TBL] [Abstract][Full Text] [Related]
3. Novel antigen delivery systems. Trovato M; De Berardinis P World J Virol; 2015 Aug; 4(3):156-68. PubMed ID: 26279977 [TBL] [Abstract][Full Text] [Related]
4. Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. De Berardinis P; Sartorius R; Caivano A; Mascolo D; Domingo GJ; Del Pozzo G; Gaubin M; Perham RN; Piatier-Tonneau D; Guardiola J Curr HIV Res; 2003 Oct; 1(4):441-6. PubMed ID: 15049429 [TBL] [Abstract][Full Text] [Related]
5. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine. Zuckermann FA; Martin S; Husmann RJ; Brandt J Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems. D'Apice L; Sartorius R; Caivano A; Mascolo D; Del Pozzo G; Di Mase DS; Ricca E; Li Pira G; Manca F; Malanga D; De Palma R; De Berardinis P Vaccine; 2007 Mar; 25(11):1993-2000. PubMed ID: 17239998 [TBL] [Abstract][Full Text] [Related]
7. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections. Calzas C; Chevalier C Front Immunol; 2019; 10():1605. PubMed ID: 31379823 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 Gag p17 presented as virus-like particles on the E2 scaffold from Geobacillus stearothermophilus induces sustained humoral and cellular immune responses in the absence of IFNγ production by CD4+ T cells. Caivano A; Doria-Rose NA; Buelow B; Sartorius R; Trovato M; D'Apice L; Domingo GJ; Sutton WF; Haigwood NL; De Berardinis P Virology; 2010 Nov; 407(2):296-305. PubMed ID: 20850858 [TBL] [Abstract][Full Text] [Related]
9. Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges. Tlaxca JL; Ellis S; Remmele RL Adv Drug Deliv Rev; 2015 Oct; 93():56-78. PubMed ID: 25312673 [TBL] [Abstract][Full Text] [Related]
10. Live bacterial vaccine vector and delivery strategies of heterologous antigen: A review. Ding C; Ma J; Dong Q; Liu Q Immunol Lett; 2018 May; 197():70-77. PubMed ID: 29550258 [TBL] [Abstract][Full Text] [Related]
11. E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. Trovato M; Maurano F; D'Apice L; Costa V; Sartorius R; Cuccaro F; McBurney SP; Krebs SJ; Prisco A; Ciccodicola A; Rossi M; Haigwood NL; De Berardinis P BMC Microbiol; 2016 Jul; 16(1):152. PubMed ID: 27421762 [TBL] [Abstract][Full Text] [Related]
12. Expression of genes encoding the E2 and E3 components of the Bacillus stearothermophilus pyruvate dehydrogenase complex and the stoichiometry of subunit interaction in assembly in vitro. Lessard IA; Domingo GJ; Borges A; Perham RN Eur J Biochem; 1998 Dec; 258(2):491-501. PubMed ID: 9874216 [TBL] [Abstract][Full Text] [Related]
13. DNA vaccines--challenges in delivery. Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641 [TBL] [Abstract][Full Text] [Related]
14. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice. Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984 [TBL] [Abstract][Full Text] [Related]
15. Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. Gaubin M; Fanutti C; Mishal Z; Durrbach A; De Berardinis P; Sartorius R; Del Pozzo G; Guardiola J; Perham RN; Piatier-Tonneau D DNA Cell Biol; 2003 Jan; 22(1):11-8. PubMed ID: 12590733 [TBL] [Abstract][Full Text] [Related]
16. Bacteriophage T4 as a Nanoparticle Platform to Display and Deliver Pathogen Antigens: Construction of an Effective Anthrax Vaccine. Tao P; Li Q; Shivachandra SB; Rao VB Methods Mol Biol; 2017; 1581():255-267. PubMed ID: 28374254 [TBL] [Abstract][Full Text] [Related]
17. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines. Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H mBio; 2019 Sep; 10(5):. PubMed ID: 31530680 [TBL] [Abstract][Full Text] [Related]
18. Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators. Tandrup Schmidt S; Foged C; Korsholm KS; Rades T; Christensen D Pharmaceutics; 2016 Mar; 8(1):. PubMed ID: 26978390 [TBL] [Abstract][Full Text] [Related]
19. Recombinant Filamentous Bacteriophages Encapsulated in Biodegradable Polymeric Microparticles for Stimulation of Innate and Adaptive Immune Responses. Jamaledin R; Sartorius R; Di Natale C; Vecchione R; De Berardinis P; Netti PA Microorganisms; 2020 Apr; 8(5):. PubMed ID: 32365728 [No Abstract] [Full Text] [Related]
20. Vectorized Delivery of Alpha-GalactosylCeramide and Tumor Antigen on Filamentous Bacteriophage fd Induces Protective Immunity by Enhancing Tumor-Specific T Cell Response. Sartorius R; D'Apice L; Barba P; Cipria D; Grauso L; Cutignano A; De Berardinis P Front Immunol; 2018; 9():1496. PubMed ID: 30002659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]